| AA-AMILZIDE (50 MG) | 00784400 | Marketed | AA Pharma Inc. | Oct 2019 |
| ACH-OLMESARTAN HCTZ (12.5 MG) | 02468948 | Marketed | Accord Healthcare Inc | Jun 2019 |
| ACH-OLMESARTAN HCTZ (12.5 MG) | 02468956 | Marketed | Accord Healthcare Inc | Jun 2019 |
| ACH-OLMESARTAN HCTZ (25 MG) | 02468964 | Marketed | Accord Healthcare Inc | Jun 2019 |
| ACH-TELMISARTAN HCTZ (12.5 MG) | 02419114 | Marketed | Accord Healthcare Inc | Nov 2014 |
| ACH-TELMISARTAN HCTZ (25 MG) | 02419122 | Marketed | Accord Healthcare Inc | Nov 2014 |
| AG TELMISARTAN-HCT (12.5 MG) | 02484560 | Marketed | Angita Pharma Inc. | Nov 2025 |
| AG TELMISARTAN-HCT (25 MG) | 02484579 | Marketed | Angita Pharma Inc. | Sep 2022 |
| APO-CILAZAPRIL/HCTZ (12.5 MG) | 02284987 | Marketed | Apotex Inc. | Aug 2006 |
| APO-HYDROCHLOROTHIAZIDE (50 MG) | 00312800 | Marketed | Apotex Inc. | Oct 2020 |
| APO-HYDROCHLOROTHIAZIDE (25 MG) | 00326844 | Marketed | Apotex Inc. | Oct 2020 |
| APO-HYDROCHLOROTHIAZIDE (12.5 MG) | 02327856 | Marketed | Apotex Inc. | Oct 2020 |
| APO-QUINAPRIL/HCTZ (12.5 MG) | 02408767 | Marketed | Apotex Inc. | Jun 2025 |
| APO-QUINAPRIL/HCTZ (12.5 MG) | 02408775 | Marketed | Apotex Inc. | Jun 2025 |
| APO-QUINAPRIL/HCTZ (25 MG) | 02408783 | Marketed | Apotex Inc. | Jun 2025 |
| APO-TRIAZIDE (25 MG) | 00441775 | Marketed | Apotex Inc. | Dec 1984 |
| ATACAND PLUS (12.5 MG) | 02244021 | Marketed | Cheplapharm Arzneimittel Gmbh | Jun 2025 |
| ATACAND PLUS (12.5 MG) | 02332922 | Marketed | Cheplapharm Arzneimittel Gmbh | Jun 2025 |
| ATACAND PLUS (25 MG) | 02332957 | Marketed | Cheplapharm Arzneimittel Gmbh | Jun 2025 |
| AURO-CANDESARTAN HCT (12.5 MG) | 02421038 | Marketed | Auro Pharma Inc. | Mar 2015 |
| AURO-CANDESARTAN HCT (12.5 MG) | 02421046 | Marketed | Auro Pharma Inc. | Mar 2015 |
| AURO-CANDESARTAN HCT (25 MG) | 02421054 | Marketed | Auro Pharma Inc. | Mar 2015 |
| AURO-LOSARTAN HCT (12.5 MG) | 02423642 | Marketed | Auro Pharma Inc. | Apr 2014 |
| AURO-LOSARTAN HCT (12.5 MG) | 02423650 | Marketed | Auro Pharma Inc. | Apr 2014 |
| AURO-LOSARTAN HCT (25 MG) | 02423669 | Marketed | Auro Pharma Inc. | Apr 2014 |
| AURO-OLMESARTAN HCTZ (12.5 MG) | 02476487 | Marketed | Auro Pharma Inc. | Jan 2019 |
| AURO-OLMESARTAN HCTZ (12.5 MG) | 02476495 | Marketed | Auro Pharma Inc. | Jan 2019 |
| AURO-OLMESARTAN HCTZ (25 MG) | 02476509 | Marketed | Auro Pharma Inc. | Jan 2019 |
| AURO-QUINAPRIL HCTZ (12.5 MG) | 02473291 | Marketed | Auro Pharma Inc. | Feb 2019 |
| AURO-QUINAPRIL HCTZ (12.5 MG) | 02473305 | Marketed | Auro Pharma Inc. | Feb 2019 |
| AURO-QUINAPRIL HCTZ (25 MG) | 02473321 | Marketed | Auro Pharma Inc. | Feb 2019 |
| AURO-TELMISARTAN HCTZ (12.5 MG) | 02456389 | Marketed | Auro Pharma Inc. | Aug 2016 |
| AURO-TELMISARTAN HCTZ (25 MG) | 02456397 | Marketed | Auro Pharma Inc. | Aug 2016 |
| AURO-VALSARTAN HCT (12.5 MG) | 02408112 | Marketed | Auro Pharma Inc. | Jun 2013 |
| AURO-VALSARTAN HCT (12.5 MG) | 02408120 | Marketed | Auro Pharma Inc. | Jun 2013 |
| AURO-VALSARTAN HCT (25 MG) | 02408139 | Marketed | Auro Pharma Inc. | Jun 2013 |
| AURO-VALSARTAN HCT (12.5 MG) | 02408147 | Marketed | Auro Pharma Inc. | Jun 2013 |
| AURO-VALSARTAN HCT (25 MG) | 02408155 | Marketed | Auro Pharma Inc. | Jun 2013 |
| AVALIDE (12.5 MG) | 02241818 | Marketed | Sanofi-Aventis Canada Inc. | Jun 2007 |
| AVALIDE (12.5 MG) | 02241819 | Marketed | Sanofi-Aventis Canada Inc. | May 2007 |
| CANDESARTAN HCT (12.5 MG) | 02394812 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2012 |
| CANDESARTAN-HCTZ (12.5 MG) | 02392275 | Marketed | Pro Doc Limitee | Oct 2012 |
| CANDESARTAN/HCTZ (12.5 MG) | 02394804 | Marketed | Sanis Health Inc. | Feb 2024 |
| CANDESARTAN/HCTZ (12.5 MG) | 02536064 | Marketed | Sanis Health Inc. | Feb 2024 |
| DIOVAN-HCT (12.5 MG) | 02241900 | Marketed | Novartis Pharmaceuticals Canada Inc. | May 2000 |
| DIOVAN-HCT (12.5 MG) | 02241901 | Marketed | Novartis Pharmaceuticals Canada Inc. | May 2000 |
| DIOVAN-HCT (25 MG) | 02246955 | Marketed | Novartis Pharmaceuticals Canada Inc. | Jan 2003 |
| DIOVAN-HCT (12.5 MG) | 02308908 | Marketed | Novartis Pharmaceuticals Canada Inc. | May 2008 |
| DIOVAN-HCT (25 MG) | 02308916 | Marketed | Novartis Pharmaceuticals Canada Inc. | May 2008 |
| ENALAPRIL MALEATE/HCTZ (12.5 MG) | 02352923 | Marketed | AA Pharma Inc. | Dec 2017 |
| ENALAPRIL MALEATE/HCTZ (25 MG) | 02352931 | Marketed | AA Pharma Inc. | Dec 2017 |
| GLN-OLMESARTAN HCTZ (12.5 MG) | 02475707 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Feb 2020 |
| GLN-OLMESARTAN HCTZ (12.5 MG) | 02475715 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Feb 2020 |
| GLN-OLMESARTAN HCTZ (25 MG) | 02475723 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Feb 2020 |
| HYDROCHLOROTHIAZIDE (25 MG) | 02360594 | Marketed | Sanis Health Inc. | Mar 2026 |
| HYDROCHLOROTHIAZIDE (25 MG) | 02486962 | Marketed | Pro Doc Limitee | Aug 2019 |
| HYZAAR (12.5 MG) | 02230047 | Marketed | Organon Canada Inc. | Mar 2022 |
| HYZAAR (12.5 MG) | 02297841 | Marketed | Organon Canada Inc. | Apr 2022 |
| HYZAAR DS (25 MG) | 02241007 | Marketed | Organon Canada Inc. | Apr 2022 |
| INHIBACE PLUS (12.5 MG) | 02181479 | Marketed | Cheplapharm Arzneimittel Gmbh | Dec 2018 |
| IRBESARTAN HCT (12.5 MG) | 02385317 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| IRBESARTAN HCT (12.5 MG) | 02385325 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| IRBESARTAN HCT (25 MG) | 02385333 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| JAMP CANDESARTAN-HCT (12.5 MG) | 02473240 | Marketed | JAMP Pharma Corporation | Mar 2020 |
| JAMP CANDESARTAN-HCT (12.5 MG) | 02473259 | Marketed | JAMP Pharma Corporation | Mar 2020 |
| JAMP CANDESARTAN-HCT (25 MG) | 02473267 | Marketed | JAMP Pharma Corporation | Mar 2020 |
| JAMP QUINAPRIL / HCTZ (12.5 MG) | 02547430 | Marketed | JAMP Pharma Corporation | Mar 2025 |
| JAMP QUINAPRIL / HCTZ (25 MG) | 02547449 | Marketed | JAMP Pharma Corporation | Mar 2025 |
| JAMP TELMISARTAN-HCT (12.5 MG) | 02389940 | Marketed | JAMP Pharma Corporation | Dec 2020 |
| JAMP TELMISARTAN-HCT (25 MG) | 02389959 | Marketed | JAMP Pharma Corporation | Dec 2020 |
| LISINOPRIL/HCTZ (TYPE Z) (12.5 MG) | 02362945 | Marketed | Sanis Health Inc. | Dec 2014 |
| LISINOPRIL/HCTZ (TYPE Z) (12.5 MG) | 02362953 | Marketed | Sanis Health Inc. | Dec 2014 |
| LISINOPRIL/HCTZ (TYPE Z) (25 MG) | 02362961 | Marketed | Sanis Health Inc. | Dec 2014 |
| LOSARTAN HCT (12.5 MG) | 02388960 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2025 |
| LOSARTAN HCT (12.5 MG) | 02388979 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2025 |
| LOSARTAN HCT DS (25 MG) | 02388987 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2025 |
| LOSARTAN/HCTZ (12.5 MG) | 02427648 | Marketed | Sanis Health Inc. | Jul 2014 |
| LOSARTAN/HCTZ (12.5 MG) | 02427656 | Marketed | Sanis Health Inc. | Aug 2020 |
| LOSARTAN/HCTZ (25 MG) | 02427664 | Marketed | Sanis Health Inc. | Jul 2014 |
| MICARDIS PLUS (12.5 MG) | 02244344 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Aug 2001 |
| MICARDIS PLUS (25 MG) | 02318709 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Dec 2008 |
| MINT-HYDROCHLOROTHIAZIDE (12.5 MG) | 02425947 | Marketed | Mint Pharmaceuticals Inc | Aug 2018 |
| MINT-HYDROCHLOROTHIAZIDE (25 MG) | 02426196 | Marketed | Mint Pharmaceuticals Inc | Aug 2018 |
| MINT-LOSARTAN/HCTZ (12.5 MG) | 02389657 | Marketed | Mint Pharmaceuticals Inc | Jun 2024 |
| MINT-LOSARTAN/HCTZ (12.5 MG) | 02389665 | Marketed | Mint Pharmaceuticals Inc | Jun 2024 |
| MINT-LOSARTAN/HCTZ DS (25.0 MG) | 02389673 | Marketed | Mint Pharmaceuticals Inc | Jun 2024 |
| NRA-CANDESARTAN HCTZ (12.5 MG) | 02531240 | Marketed | Nora Pharma Inc. | Jul 2023 |
| NRA-CANDESARTAN HCTZ (12.5 MG) | 02531259 | Marketed | Nora Pharma Inc. | Jul 2023 |
| NRA-CANDESARTAN HCTZ (25 MG) | 02531267 | Marketed | Nora Pharma Inc. | Jul 2023 |
| NRA-OLMESARTAN HCTZ (12.5 MG) | 02508273 | Marketed | Nora Pharma Inc. | Jul 2021 |
| NRA-OLMESARTAN HCTZ (12.5 MG) | 02508281 | Marketed | Nora Pharma Inc. | Jul 2021 |
| NRA-OLMESARTAN HCTZ (25 MG) | 02508303 | Marketed | Nora Pharma Inc. | Jul 2021 |
| NRA-TELMISARTAN/HCTZ (25 MG) | 02504138 | Marketed | Nora Pharma Inc. | Oct 2024 |
| NRA-TELMISARTAN/HCTZ (12.5 MG) | 02504146 | Marketed | Nora Pharma Inc. | Oct 2024 |
| OLMESARTAN/HCTZ (12.5 MG) | 02509601 | Marketed | Sanis Health Inc. | Apr 2026 |
| OLMESARTAN/HCTZ (25 MG) | 02509628 | Marketed | Sanis Health Inc. | Apr 2026 |
| OLMESARTAN/HCTZ (12.5 MG) | 02509636 | Marketed | Sanis Health Inc. | Apr 2026 |
| OLMETEC PLUS (12.5 MG) | 02319616 | Marketed | Organon Canada Inc. | Oct 2022 |
| OLMETEC PLUS (12.5 MG) | 02319624 | Marketed | Organon Canada Inc. | Jan 2023 |
| OLMETEC PLUS (25 MG) | 02319632 | Marketed | Organon Canada Inc. | Dec 2022 |
| PMS-CANDESARTAN-HCTZ (12.5 MG) | 02391295 | Marketed | Pharmascience Inc. | Sep 2012 |
| PMS-HYDROCHLOROTHIAZIDE (25 MG) | 02247386 | Marketed | Pharmascience Inc. | May 2014 |
| PMS-HYDROCHLOROTHIAZIDE (50 MG) | 02247387 | Marketed | Pharmascience Inc. | Oct 2013 |
| PMS-HYDROCHLOROTHIAZIDE (12.5 MG) | 02274086 | Marketed | Pharmascience Inc. | Nov 2013 |
| PMS-IRBESARTAN-HCTZ (12.5 MG) | 02328518 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-IRBESARTAN-HCTZ (12.5 MG) | 02328526 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-IRBESARTAN-HCTZ (25 MG) | 02328534 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-LOSARTAN-HCTZ (12.5 MG) | 02392224 | Marketed | Pharmascience Inc. | Sep 2012 |
| PMS-LOSARTAN-HCTZ (12.5 MG) | 02392232 | Marketed | Pharmascience Inc. | Sep 2012 |
| PMS-LOSARTAN-HCTZ (25 MG) | 02392240 | Marketed | Pharmascience Inc. | Sep 2012 |
| PMS-RAMIPRIL-HCTZ (12.5 MG) | 02342154 | Marketed | Pharmascience Inc. | Feb 2010 |
| PMS-RAMIPRIL-HCTZ (25.0 MG) | 02342170 | Marketed | Pharmascience Inc. | Feb 2010 |
| PRO-IRBESARTAN-HCTZ (12.5 MG) | 02365162 | Marketed | Pro Doc Limitee | Mar 2026 |
| PRO-IRBESARTAN-HCTZ (12.5 MG) | 02365170 | Marketed | Pro Doc Limitee | Mar 2026 |
| PRO-IRBESARTAN-HCTZ (25 MG) | 02365189 | Marketed | Pro Doc Limitee | Mar 2026 |
| PRO-TELMISARTAN-HCTZ (12.5 MG) | 02395525 | Marketed | Pro Doc Limitee | Jan 2026 |
| PRO-TELMISARTAN-HCTZ (25 MG) | 02395533 | Marketed | Pro Doc Limitee | May 2026 |
| SANDOZ CANDESARTAN PLUS (12.5 MG) | 02327902 | Marketed | Sandoz Canada Inc. | Sep 2012 |
| SANDOZ CANDESARTAN PLUS (12.5 MG) | 02420732 | Marketed | Sandoz Canada Inc. | Feb 2014 |
| SANDOZ CANDESARTAN PLUS (25 MG) | 02420740 | Marketed | Sandoz Canada Inc. | Feb 2014 |
| SANDOZ IRBESARTAN HCT (12.5 MG) | 02337428 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ IRBESARTAN HCT (12.5 MG) | 02337436 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ IRBESARTAN HCT (25 MG) | 02337444 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ LISINOPRIL HCT (12.5 MG) | 02302365 | Marketed | Sandoz Canada Inc. | Nov 2007 |
| SANDOZ LISINOPRIL HCT (12.5 MG) | 02302373 | Marketed | Sandoz Canada Inc. | Nov 2007 |
| SANDOZ LISINOPRIL HCT (25 MG) | 02302381 | Marketed | Sandoz Canada Inc. | Nov 2007 |
| SANDOZ LOSARTAN HCT (12.5 MG) | 02313375 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ LOSARTAN HCT (12.5 MG) | 02362449 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ LOSARTAN HCT DS (25 MG) | 02313383 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ TELMISARTAN HCT (12.5 MG) | 02393557 | Marketed | Sandoz Canada Inc. | Sep 2012 |
| SANDOZ TELMISARTAN HCT (25 MG) | 02393565 | Marketed | Sandoz Canada Inc. | Sep 2012 |
| SANDOZ VALSARTAN HCT (12.5 MG) | 02356694 | Marketed | Sandoz Canada Inc. | May 2016 |
| SANDOZ VALSARTAN HCT (12.5 MG) | 02356708 | Marketed | Sandoz Canada Inc. | May 2016 |
| SANDOZ VALSARTAN HCT (25 MG) | 02356716 | Marketed | Sandoz Canada Inc. | May 2016 |
| SANDOZ VALSARTAN HCT (12.5 MG) | 02356724 | Marketed | Sandoz Canada Inc. | May 2016 |
| SANDOZ VALSARTAN HCT (25 MG) | 02356732 | Marketed | Sandoz Canada Inc. | May 2016 |
| TARO-RAMIPRIL HCTZ (12.5 MG) | 02449439 | Marketed | Sun Pharma Canada Inc. | Nov 2023 |
| TARO-RAMIPRIL HCTZ (12.5 MG) | 02449447 | Marketed | Sun Pharma Canada Inc. | Dec 2023 |
| TARO-RAMIPRIL HCTZ (12.5 MG) | 02449455 | Marketed | Sun Pharma Canada Inc. | Dec 2023 |
| TARO-RAMIPRIL HCTZ (25 MG) | 02449463 | Marketed | Sun Pharma Canada Inc. | Dec 2023 |
| TARO-RAMIPRIL HCTZ (25 MG) | 02449471 | Marketed | Sun Pharma Canada Inc. | Nov 2023 |
| TELMISARTAN HCTZ (12.5 MG) | 02390302 | Marketed | Sivem Pharmaceuticals Ulc | Aug 2025 |
| TELMISARTAN HCTZ (25 MG) | 02390310 | Marketed | Sivem Pharmaceuticals Ulc | Aug 2025 |
| TELMISARTAN/HCTZ (12.5 MG) | 02395355 | Marketed | Sanis Health Inc. | Nov 2012 |
| TELMISARTAN/HCTZ (25 MG) | 02395363 | Marketed | Sanis Health Inc. | Nov 2012 |
| TEVA-CANDESARTAN/HCTZ (12.5 MG) | 02395541 | Marketed | Teva Canada Limited | Sep 2013 |
| TEVA-CANDESARTAN/HCTZ (12.5 MG) | 02395568 | Marketed | Teva Canada Limited | Jun 2013 |
| TEVA-HYDROCHLOROTHIAZIDE (25 MG) | 00021474 | Marketed | Teva Canada Limited | Feb 2011 |
| TEVA-HYDROCHLOROTHIAZIDE (50 MG) | 00021482 | Marketed | Teva Canada Limited | Feb 2011 |
| TEVA-IRBESARTAN HCTZ (12.5 MG) | 02330512 | Marketed | Teva Canada Limited | Jun 2018 |
| TEVA-IRBESARTAN HCTZ (12.5 MG) | 02330520 | Marketed | Teva Canada Limited | Jun 2018 |
| TEVA-IRBESARTAN HCTZ (25 MG) | 02330539 | Marketed | Teva Canada Limited | Jun 2018 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) (12.5 MG) | 02301768 | Marketed | Teva Canada Limited | Dec 2010 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) (12.5 MG) | 02301776 | Marketed | Teva Canada Limited | Dec 2010 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) (25 MG) | 02301784 | Marketed | Teva Canada Limited | Dec 2010 |
| TEVA-OLMESARTAN / HCTZ (12.5 MG) | 02443112 | Marketed | Teva Canada Limited | Dec 2023 |
| TEVA-OLMESARTAN / HCTZ (12.5 MG) | 02443120 | Marketed | Teva Canada Limited | Dec 2023 |
| TEVA-OLMESARTAN / HCTZ (25 MG) | 02443139 | Marketed | Teva Canada Limited | Dec 2023 |
| TEVA-SPIRONOLACTONE/HCTZ (25 MG) | 00613231 | Marketed | Teva Canada Limited | Jun 2011 |
| TEVA-SPIRONOLACTONE/HCTZ (50 MG) | 00657182 | Marketed | Teva Canada Limited | Jun 2011 |
| TEVA-TELMISARTAN HCTZ (12.5 MG) | 02330288 | Marketed | Teva Canada Limited | Feb 2012 |
| TEVA-TELMISARTAN HCTZ (25.0 MG) | 02379252 | Marketed | Teva Canada Limited | Feb 2012 |
| TEVA-TRIAMTERENE/HCTZ (25 MG) | 00532657 | Marketed | Teva Canada Limited | May 2011 |
| TEVA-VALSARTAN/HCTZ (12.5 MG) | 02356996 | Marketed | Teva Canada Limited | Feb 2011 |
| TEVA-VALSARTAN/HCTZ (12.5 MG) | 02357003 | Marketed | Teva Canada Limited | Feb 2011 |
| TEVA-VALSARTAN/HCTZ (25 MG) | 02357011 | Marketed | Teva Canada Limited | Feb 2011 |
| TEVA-VALSARTAN/HCTZ (12.5 MG) | 02357038 | Marketed | Teva Canada Limited | Feb 2011 |
| TEVA-VALSARTAN/HCTZ (25 MG) | 02357046 | Marketed | Teva Canada Limited | Feb 2011 |
| VALSARTAN HCT (12.5 MG) | 02367009 | Marketed | Sanis Health Inc. | Feb 2022 |
| VALSARTAN HCT (12.5 MG) | 02367017 | Marketed | Sanis Health Inc. | Feb 2022 |
| VALSARTAN HCT (25 MG) | 02367025 | Marketed | Sanis Health Inc. | Feb 2022 |
| VALSARTAN HCT (12.5 MG) | 02367033 | Marketed | Sanis Health Inc. | Feb 2022 |
| VALSARTAN HCT (25 MG) | 02367041 | Marketed | Sanis Health Inc. | Feb 2022 |
| VALSARTAN HCT (12.5 MG) | 02384736 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| VALSARTAN HCT (12.5 MG) | 02384744 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| VALSARTAN HCT (25 MG) | 02384752 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| VALSARTAN HCT (12.5 MG) | 02384760 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| VALSARTAN-HCTZ (12.5 MG) | 02367769 | Marketed | Pro Doc Limitee | Jan 2022 |
| VALSARTAN-HCTZ (12.5 MG) | 02367777 | Marketed | Pro Doc Limitee | Jan 2022 |
| VALSARTAN-HCTZ (25 MG) | 02367785 | Marketed | Pro Doc Limitee | Jan 2022 |
| VASERETIC (25 MG) | 00657298 | Marketed | Organon Canada Inc. | Feb 2022 |
| ZESTORETIC (12.5 MG) | 02103729 | Marketed | Searchlight Pharma Inc. | Feb 2022 |
| ZESTORETIC (12.5 MG) | 02045737 | Marketed | Searchlight Pharma Inc. | Feb 2022 |
| ZESTORETIC (25 MG) | 02045729 | Marketed | Searchlight Pharma Inc. | Jul 2021 |
| AG-CANDESARTAN HCT (12.5 MG) | 02500744 | Approved | Angita Pharma Inc. | Jun 2020 |
| AG-CANDESARTAN HCT (12.5 MG) | 02500752 | Approved | Angita Pharma Inc. | Jun 2020 |
| AG-CANDESARTAN HCT (25 MG) | 02500760 | Approved | Angita Pharma Inc. | Jun 2020 |
| AG-OLMESARTAN HCTZ (12.5 MG) | 02478676 | Approved | Angita Pharma Inc. | Jul 2018 |
| AG-OLMESARTAN HCTZ (12.5 MG) | 02478668 | Approved | Angita Pharma Inc. | Jul 2018 |
| AG-OLMESARTAN HCTZ (25 MG) | 02478684 | Approved | Angita Pharma Inc. | Jul 2018 |
| ALEMBIC-TELMISARTAN/HCTZ (12.5 MG) | 02442884 | Approved | Alembic Pharmaceuticals Limited | Aug 2018 |
| ALEMBIC-TELMISARTAN/HCTZ (25 MG) | 02442892 | Approved | Alembic Pharmaceuticals Limited | Aug 2018 |
| ALTACE HCT (12.5 MG) | 02283131 | Dormant | Bausch Health, Canada Inc. | Jul 2024 |
| ALTACE HCT (12.5 MG) | 02283158 | Dormant | Bausch Health, Canada Inc. | Jul 2026 |
| ALTACE HCT (12.5 MG) | 02283166 | Dormant | Bausch Health, Canada Inc. | Jul 2026 |
| ALTACE HCT (25 MG) | 02283174 | Dormant | Bausch Health, Canada Inc. | Jul 2024 |
| ALTACE HCT (25 MG) | 02283182 | Dormant | Bausch Health, Canada Inc. | Jul 2025 |
| APO-CANDESARTAN/HCTZ (12.5 MG) | 02367866 | Dormant | Apotex Inc. | Aug 2019 |
| APO-CANDESARTAN/HCTZ (12.5 MG) | 02395126 | Dormant | Apotex Inc. | Aug 2019 |
| APO-CANDESARTAN/HCTZ (25 MG) | 02395134 | Dormant | Apotex Inc. | Aug 2019 |
| APO-HYDROCHLOROTHIAZIDE (100 MG) | 00644552 | Dormant | Apotex Inc. | Oct 2020 |
| APO-IRBESARTAN/HCTZ (12.5 MG) | 02387646 | Dormant | Apotex Inc. | May 2019 |
| APO-IRBESARTAN/HCTZ (12.5 MG) | 02387654 | Dormant | Apotex Inc. | May 2019 |
| APO-IRBESARTAN/HCTZ (25 MG) | 02387662 | Dormant | Apotex Inc. | Aug 2019 |
| APO-LISINOPRIL/HCTZ (12.5 MG) | 02261979 | Dormant | Apotex Inc. | Aug 2017 |
| APO-LISINOPRIL/HCTZ (12.5 MG) | 02261987 | Dormant | Apotex Inc. | Aug 2017 |
| APO-LISINOPRIL/HCTZ (25 MG) | 02261995 | Dormant | Apotex Inc. | Aug 2017 |
| APO-OLMESARTAN/HCTZ (12.5 MG) | 02453606 | Dormant | Apotex Inc. | Oct 2025 |
| APO-OLMESARTAN/HCTZ (12.5 MG) | 02453614 | Dormant | Apotex Inc. | Oct 2025 |
| APO-OLMESARTAN/HCTZ (25 MG) | 02453622 | Dormant | Apotex Inc. | Oct 2025 |
| APO-QUINAPRIL / HCTZ TABLETS (12.5 MG) | 02533502 | Approved | Apotex Inc. | Dec 2022 |
| APO-QUINAPRIL / HCTZ TABLETS (12.5 MG) | 02533510 | Approved | Apotex Inc. | Dec 2022 |
| APO-QUINAPRIL / HCTZ TABLETS (25 MG) | 02533529 | Approved | Apotex Inc. | Dec 2022 |
| APO-RAMIPRIL/HCTZ (12.5 MG) | 02354004 | Approved | Apotex Inc. | Jul 2010 |
| APO-RAMIPRIL/HCTZ (12.5 MG) | 02354012 | Approved | Apotex Inc. | Jul 2010 |
| APO-RAMIPRIL/HCTZ (25 MG) | 02354020 | Approved | Apotex Inc. | Jul 2010 |
| APO-RAMIPRIL/HCTZ (25 MG) | 02354039 | Approved | Apotex Inc. | Jul 2010 |
| APO-RAMIPRIL/HCTZ (12.5 MG) | 02368722 | Approved | Apotex Inc. | Jun 2011 |
| AURO-IRBESARTAN HCT (12.5 MG) | 02447878 | Dormant | Auro Pharma Inc. | Jul 2020 |
| AURO-IRBESARTAN HCT (12.5 MG) | 02447886 | Dormant | Auro Pharma Inc. | Jul 2020 |
| AURO-IRBESARTAN HCT (25 MG) | 02447894 | Dormant | Auro Pharma Inc. | Jul 2020 |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (12.5 MG) | 02405210 | Approved | Jubilant Generics Limited | Jul 2014 |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (25.0 MG) | 02405229 | Approved | Jubilant Generics Limited | Jul 2014 |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS (12.5 MG) | 02426110 | Approved | Alembic Pharmaceuticals Limited | Jun 2014 |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS (25 MG) | 02426129 | Approved | Alembic Pharmaceuticals Limited | Jun 2014 |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS (12.5 MG) | 02459124 | Approved | Alembic Pharmaceuticals Limited | Nov 2016 |
| CANDESARTAN/HCTZ (25 MG) | 02536072 | Approved | Sanis Health Inc. | Mar 2023 |
| HYDROCHLOROTHIAZIDE (50 MG) | 02360608 | Dormant | Sanis Health Inc. | Mar 2026 |
| HYDROCHLOROTHIAZIDE (50 MG) | 02486970 | Approved | Pro Doc Limitee | Apr 2019 |
| HYDROCHLOROTHIAZIDE (12.5 MG) | 02566796 | Approved | Sanis Health Inc. | Mar 2026 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE (12.5 MG) | 02404001 | Approved | Jubilant Generics Limited | Mar 2013 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE (12.5 MG) | 02404028 | Approved | Jubilant Generics Limited | Mar 2013 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE (25 MG) | 02404036 | Approved | Jubilant Generics Limited | Mar 2013 |
| IRBESARTAN/HCTZ (12.5 MG) | 02372886 | Dormant | Sanis Health Inc. | Jul 2026 |
| IRBESARTAN/HCTZ (12.5 MG) | 02372894 | Dormant | Sanis Health Inc. | Jul 2026 |
| IRBESARTAN/HCTZ (25 MG) | 02372908 | Dormant | Sanis Health Inc. | Jul 2026 |
| JAMP-OLMESARTAN HCTZ (12.5 MG) | 02462036 | Dormant | JAMP Pharma Corporation | Aug 2019 |
| JAMP-OLMESARTAN HCTZ (12.5 MG) | 02462044 | Dormant | JAMP Pharma Corporation | Aug 2019 |
| JAMP-OLMESARTAN HCTZ (25 MG) | 02462052 | Dormant | JAMP Pharma Corporation | Aug 2019 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (12.5 MG) | 02396572 | Approved | Jubilant Generics Limited | May 2013 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (25 MG) | 02396580 | Approved | Jubilant Generics Limited | May 2013 |
| MAR-CANDESARTAN / HCTZ (12.5 MG) | 02432323 | Approved | Marcan Pharmaceuticals Inc. | Feb 2017 |
| MAR-CANDESARTAN / HCTZ (25 MG) | 02432358 | Approved | Marcan Pharmaceuticals Inc. | Feb 2017 |
| MAR-CANDESARTAN / HCTZ (12.5 MG) | 02460483 | Approved | Marcan Pharmaceuticals Inc. | Feb 2017 |
| MINT-HYDROCHLOROTHIAZIDE (50 MG) | 02426218 | Dormant | Mint Pharmaceuticals Inc | Aug 2018 |
| NB-CANDESARTAN HCT (12.5 MG) | 02568632 | Approved | NB Pharma Inc. | May 2026 |
| NB-CANDESARTAN HCT (12.5 MG) | 02568640 | Approved | NB Pharma Inc. | May 2026 |
| NB-CANDESARTAN HCT (25 MG) | 02568659 | Approved | NB Pharma Inc. | May 2026 |
| NB-IRBESARTAN HCT (12.5 MG) | 02570211 | Approved | NB Pharma Inc. | Jul 2026 |
| NB-IRBESARTAN HCT (12.5 MG) | 02570238 | Approved | NB Pharma Inc. | Jul 2026 |
| NB-IRBESARTAN HCT (25 MG) | 02570246 | Approved | NB Pharma Inc. | Jul 2026 |
| OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE (12.5 MG) | 02455072 | Approved | Jubilant Generics Limited | May 2017 |
| OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE (12.5 MG) | 02455080 | Approved | Jubilant Generics Limited | May 2017 |
| OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE (25 MG) | 02455099 | Approved | Jubilant Generics Limited | May 2017 |
| PENDO-IRBESARTAN-HCTZ (12.5 MG) | 02427214 | Approved | Pendopharm Division Of Pharmascience Inc | Jul 2014 |
| PENDO-TELMISARTAN-HCTZ (12.5 MG) | 02427230 | Approved | Pendopharm Division Of Pharmascience Inc | Jul 2014 |
| PENDO-TELMISARTAN-HCTZ (25 MG) | 02427249 | Approved | Pendopharm Division Of Pharmascience Inc | Aug 2014 |
| PRZ-OLMESARTAN/HCTZ (12.5 MG) | 02526468 | Dormant | Pharmaris Canada Inc. | Jun 2025 |
| PRZ-OLMESARTAN/HCTZ (12.5 MG) | 02526476 | Dormant | Pharmaris Canada Inc. | Jun 2025 |
| PRZ-OLMESARTAN/HCTZ (25 MG) | 02526484 | Dormant | Pharmaris Canada Inc. | Jun 2025 |
| SEPTA-CANDESARTAN HCTZ (12.5 MG) | 02440261 | Approved | Septa Pharmaceuticals Inc | Apr 2015 |
| SEPTA-CANDESARTAN HCTZ (25 MG) | 02440288 | Approved | Septa Pharmaceuticals Inc | Apr 2015 |
| SEPTA-LOSARTAN HCTZ (12.5 MG) | 02428539 | Dormant | Septa Pharmaceuticals Inc | Jul 2017 |
| SEPTA-LOSARTAN HCTZ (25 MG) | 02428547 | Dormant | Septa Pharmaceuticals Inc | Jul 2017 |
| TELMISARTAN-HCTZ (25 MG) | 02433222 | Dormant | Pharmascience Inc. | Oct 2018 |
| UROZIDE (25 MG) | 00263893 | Dormant | Biomed Pharma | Aug 2017 |
| UROZIDE (50 MG) | 00263907 | Dormant | Biomed Pharma | Aug 2017 |
| UROZIDE (100 MG) | 00405620 | Dormant | Biomed Pharma | Aug 2017 |
| VALSARTAN-HCTZ (12.5 MG) | 02524171 | Approved | Pro Doc Limitee | Jan 2022 |
| VALSARTAN-HCTZ (25 MG) | 02524201 | Approved | Pro Doc Limitee | Jan 2022 |
| VISKAZIDE (25 MG) | 00568627 | Dormant | Xediton Pharmaceuticals Inc. | Sep 2025 |
| VISKAZIDE (50 MG) | 00568635 | Dormant | Xediton Pharmaceuticals Inc. | Sep 2025 |
| ACCEL-CANDESARTAN/HCTZ (12.5 MG) | 02463849 | Cancelled Post Market | Accel Pharma Inc | Mar 2020 |
| ACCEL-CANDESARTAN/HCTZ (25 MG) | 02463857 | Cancelled Post Market | Accel Pharma Inc | Mar 2020 |
| ACCEL-CANDESARTAN/HCTZ (12.5 MG) | 02463865 | Cancelled Post Market | Accel Pharma Inc | Mar 2020 |
| ACCURETIC (12.5 MG) | 02237367 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2024 |
| ACCURETIC (12.5 MG) | 02237368 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2024 |
| ACCURETIC (25 MG) | 02237369 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2024 |
| ACT CANDESARTAN/HCT (12.5 MG) | 02388650 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN/HCT (12.5 MG) | 02357399 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN/HCT (12.5 MG) | 02357402 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN/HCT (25 MG) | 02357410 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT LOSARTAN/HCT (12.5 MG) | 02388251 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT LOSARTAN/HCT (12.5 MG) | 02388278 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT LOSARTAN/HCT (25 MG) | 02388286 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT TELMISARTAN/HCT (12.5 MG) | 02393263 | Cancelled Post Market | Actavis Pharma Company | Apr 2018 |
| ACT TELMISARTAN/HCT (25 MG) | 02393271 | Cancelled Post Market | Actavis Pharma Company | Apr 2018 |
| AG-IRBESARTAN HCTZ (12.5 MG) | 02476428 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-IRBESARTAN HCTZ (12.5 MG) | 02476444 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-IRBESARTAN HCTZ (25 MG) | 02476436 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-LOSARTAN HCTZ (12.5 MG) | 02474654 | Cancelled Pre Market | Angita Pharma Inc. | Sep 2022 |
| AG-LOSARTAN HCTZ (25 MG) | 02474662 | Cancelled Pre Market | Angita Pharma Inc. | Sep 2022 |
| ALDACTAZIDE 25 (25 MG) | 00180408 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2020 |
| ALDACTAZIDE 50 (50 MG) | 00594377 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2020 |
| ALDORIL 15 TAB (15 MG) | 00140589 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Aug 1998 |
| ALDORIL 25 TAB (25 MG) | 00140597 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Mar 1999 |
| ALTI-AMILORIDE HCTZ (50 MG) | 02174596 | Cancelled Post Market | Altimed Pharma Inc. | Aug 2004 |
| AMI-HYDRO TAB (50 MG) | 00870943 | Cancelled Post Market | Pro Doc Limitee | May 2017 |
| APO METHAZIDE 15 (15 MG) | 00441708 | Cancelled Post Market | Apotex Inc. | May 2019 |
| APO METHAZIDE 25 (25 MG) | 00441716 | Cancelled Post Market | Apotex Inc. | May 2019 |